参考文献/References:
[1]Drouillard A,Manfredi S,Lepage C,et al.Epidemiology of pancreatic cancer[J].Bull Cancer,2018,105(1):63-69.[2]Buha A,Wallace D,Djordjevic V,et al.Cadmium exposure as a putative risk factor for the development of pancreatic cancer:Three different lines of evidence[J].Biomed Res Int,2017,2017:1981837.[3]Rahib L,Smith BD,Aizenberg R,et al.Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States[J].Cancer Res,2014,74(11):2913-2921. [4]Malvezzi M,Bertuccio P,Levi F,et al.European cancer mortality predictions for the year 2014[J].Ann Oncol,2014,25(8):1650-1656.[5]Wei W,Zeng H,Zheng R,et al.Cancer registration in China and its role in cancer prevention and control[J].Lancet Oncol,2020,21(7):342-349.[6]Jin D,Jiao Y,Ji J,et al.Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis[J].Peer J,2020,8(18):e9301.[7]Singhi AD,Koay EJ,Chari ST,et al.Early Detection of Pancreatic Cancer: Opportunities and Challenges[J].Gastroenterology,2019,156(7):2024-2040.[8]Midha S,Sreenivas V,Kabra M,et al.Genetically determined chronic pancreatitis but not alcoholic pancreatitis is a strong risk factor for pancreatic cancer[J].Pancreas,2016,45(10):1478-1484. [9]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[10]Bosetti C,Bertuccio P,Negri E,et al.Pancreaticcancer:overview of descriptive epidemiology[J].Mol Carcinog,2012,51(1):3-13.[11]Genkinger JM,Spiegelman D,Anderson KE,et al.A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk[J].Int J Cancer,2011,129(7):1708-1717.[12]Gani F,Johnston FM,Nelson-Williams H,et al.Hospitalvolume and the costs associated with surgery for pancreatic cancer[J].J Gastrointest Surg,2017,21(9):1411-1419.[13]Capocaccia R,Gatta G,Micheli A,et al.EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary[J].Ann Oncol,2003,14 Suppl 5:v61-v118.[14]Midha S,Chawla S,Garg PK.Modifiable and non-modifiable risk factors for pancreatic cancer:A review[J].Cancer Lett,2016,381(1):269-277.[15]Bo X,Shi J,Liu R,et al.Using the risk factors of pancreatic cancer and their interactions in cancer screening: acase-control study in shanghai, China[J].Ann Glob Health,2019,85(1):103.[16]Ilic M,Ilic I.Epidemiology of pancreatic cancer[J].World J Gastroenterol,2016,22(44):9694-9705.[17]Hruban RH,Canto MI,Goggins M,et al.Update on familial pancreatic cancer[J].Adv Surg,2010,44:293-311.[18]Macklin SK,Kasi PM,Jackson JL,et al.Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer[J].Front Oncol,2018,8:330.[19]Hassan MM,Bondy ML,Wolff RA,et al.Risk factors for pancreatic cancer: case-control study[J].American Journal of Gastroenterology,2007,102(12):2696.[20]Liao KF,Lai SW,Li CI,et al.Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan[J].J Gastroenterol Hepatol,2012,27(4):709-713.[21]Menini S,Iacobini C,Vitale M,et al.Diabetes and Pancreatic Cancer-A Dangerous Liaison Relying on Carbonyl Stress[J].Cancers (Basel),2021,13(2):313.[22]You JH,Song SO,Kang MJ,et al.Metformin and gastrointestinal cancer development in newly diagnosed type 2 diabetes: a population-based study in Korea[J].Clin Transl Gastroenterol,2020,11(11):e00254.[23]Grote VA,Rohrmann S,Nieters A,et al.Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort[J].Diabetologia,2011,54(12):3037-3046.[24]Zhang C,Qin YY,Chen Q,et al.Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies[J].Int J Cardiol,2014,174(3):669-677.[25]Lugo A,Peveri G,Bosetti C,et al.Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis[J].Eur J Cancer,2018,104:117-126.[26]Zhang Y,Zhu S,Yuan Z,et al.Risk factors and socio-economic burden in pancreatic ductal adenocarcinoma operation: a machine learning based analysis[J].BMC Cancer,2020,20(1):1161.[27]Maisonneuve P,Lowenfels AB.Risk factors for pancreatic cancer: a summary review of meta-analytical studies[J].Int J Epidemiol,2015,44(1):186-198.[28]Xu S,Chheda C,Ouhaddi Y,et al.Characterization of mouse models of early pancreatic lesions induced by alcohol and chronic pancreatitis[J].Pancreas,2015,44(6):882-887. [29]Quail DF,Joyce JA.Molecularpathways:deciphering mechanisms of resistance to macrophage-targeted therapies[J].Clin Cancer Res,2017,23(4):876-884. [30]Dawson DW,Hertzer K,Moro A,et al.High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model[J].Cancer Prev Res (Phila),2013,6(10):1064-1073.[31]Kwon H,Pessin JE.Adipokines mediate inflammation and insulin resistance[J].Front Endocrinol(Lausanne),2013,4:71.[32]Hertzer KM,Xu M,Moro A,et al.Robustearly inflammation of the peripancreatic visceral adipose tissue during diet-induced obesity in the KrasG12D model of pancreatic cancer[J].Pancreas,2016,45(3):458-465.[33]Xu M,Jung X,Hines OJ,et al.Obesity and pancreatic cancer: overview of epidemiology and potential prevention by weight loss[J].Pancreas,2018,47(2):158-162.[34]张洁.Notch信号通路在慢性胰腺炎诱导胰腺癌发生过程中的作用机制[D].北京:北京协和医学院,2012.[35]Kirkeg?覽rd J,Mortensen FV,Cronin-Fenton D.Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J].Am J Gastroenterol,2017,112(9):1366-1372.[36]Raimondi S,Lowenfels AB,Morselli-Labate AM,et al.Pancreatic cancer in chronic pancreatitis, aetiology, incidence, and early detection[J].Best Pract Res Clin Gastroenterol,2010,24(3):349–358.[37]Zhang Y,Zhu SB,Yuan ZQ,et al.Risk factors and socio-economic burden in pancreatic ductal adenocarcinoma operation: a machine learning based analysis[J].BMC Cancer,2020,20(1):1161.[38]Song J,Sokoll LJ,Pasay JJ,et al.Identification of serum biomarker panels for the early detection of pancreatic cancer[J].Cancer Epidemiol Biomarkers Prev,2019,28(1):174-182.[39]Ansari D,Gustafsson A,Andersson R.Update on the management of pancreatic cancer: surgery is not enough[J].World J Gastroenterol,2015,21(11):3157-3165.[40]Choe JW,Kim HJ,Kim JS,et al.Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes[J].Hepatobiliary Pancreat Dis Int,2018,17(3):263-268.[41]Fahrmann JF,Bantis LE,Capello M,et al.A plasma-derived Protein-metabolite multiplexed panel for early-stage pancreatic cancer[J].J Natl Cancer Inst,2019,111(4):372-379. [42]DaVee T,Coronel E,Papafragkakis C,et al.Pancreatic cancer screening in high-risk individuals with germline genetic mutations[J].Gastrointest Endosc,2018,87(6):1443-1450.[43]Capello M,Bantis LE,Scelo G,et al.Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer[J].J Natl Cancer Inst,2017,109(4):djw266.
相似文献/References:
[1]赵霓姗.胰腺癌主要危险因素及作用机制研究[J].医学信息,2020,33(03):56.[doi:10.3969/j.issn.1006-1959.2020.03.017]
ZHAO Ni-shan.Study on the Main Risk Factors and Mechanism of Pancreatic Cancer[J].Medical Information,2020,33(11):56.[doi:10.3969/j.issn.1006-1959.2020.03.017]
[2]周国斌,柳登平.磁共振和经腹部彩超对胰腺癌与肿块型胰腺炎的鉴别诊断价值分析[J].医学信息,2022,35(17):99.[doi:10.3969/j.issn.1006-1959.2022.17.026]
ZHOU Guo-bin,LIU Deng-ping.Value of Magnetic Resonance and Transabdominal Ultrasonography in Differential Diagnosis of Pancreatic Carcinoma and Mass-type Pancreatitis[J].Medical Information,2022,35(11):99.[doi:10.3969/j.issn.1006-1959.2022.17.026]
[3]毕凌波,尹 翠,张奉明,等.转基因敲除TRA1/TRPV1离子通道表达在慢性胰腺炎疼痛中的调控作用[J].医学信息,2020,33(15):65.[doi:10.3969/j.issn.1006-1959.2020.15.021]
BI Ling-bo,YIN Cui,ZHANG Feng-ming,et al.The Regulatory Role of Transgenic Knockout TRA1/TRPV1 Ion Channel Expressionin Chronic Pancreatitis Pain[J].Medical Information,2020,33(11):65.[doi:10.3969/j.issn.1006-1959.2020.15.021]
[4]漆处梅,唐小龙.胰腺癌患者BZW1和BZW2表达水平及其与预后的相关性分析[J].医学信息,2022,35(21):26.[doi:10.3969/j.issn.1006-1959.2022.21.006]
QI Chu-mei,TANG Xiao-long.Expression of BZW1 and BZW2 in Pancreatic Cancer and its Correlation with Prognosis[J].Medical Information,2022,35(11):26.[doi:10.3969/j.issn.1006-1959.2022.21.006]
[5]王雨娜,吴冬桂,赵 贝.基于数据挖掘AGR2在胰腺癌中的表达及预后潜力[J].医学信息,2022,35(22):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
WANG Yu-na,WU Dong-gui,ZHAO Bei.Expression and Prognostic Potential of AGR2 in Pancreatic Cancer Based on Data Mining[J].Medical Information,2022,35(11):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
[6]张文娟,边 伟,王炳超,等.miR-381在胰腺癌患者组织及外周血的表达及临床价值[J].医学信息,2021,34(06):111.[doi:10.3969/j.issn.1006-1959.2021.06.028]
ZHANG Wen-juan,BIAN Wei,WANG Bing-chao,et al.The Expression and Clinical Value of miR-381 in Tissues and Peripheral Blood of Patients with Pancreatic Cancer[J].Medical Information,2021,34(11):111.[doi:10.3969/j.issn.1006-1959.2021.06.028]
[7]王宇路,王苏平,赵雪梅,等.磁共振胰胆管成像对肿块型胰腺炎与胰腺癌的诊断价值[J].医学信息,2021,34(13):176.[doi:10.3969/j.issn.1006-1959.2021.13.049]
WANG Yu-lu,WANG Su-ping,ZHAO Xue-mei,et al.The Value of Magnetic Resonance Cholangiopancreatography in the Differential Diagnosis of Mass Forming ChronicPancreatitis and Pancreatic Cancer[J].Medical Information,2021,34(11):176.[doi:10.3969/j.issn.1006-1959.2021.13.049]
[8]刘 基,孙振纲,邓 岩,等.炎症对胰腺癌患者预后的评估及免疫状态的影响[J].医学信息,2023,36(05):13.[doi:10.3969/j.issn.1006-1959.2023.05.003]
LIU Ji,SUN Zhen-gang,DENG Yan,et al.Effects of Inflammation on Prognosis and Immune Status in Patients with Pancreatic Adenocarcinoma[J].Medical Information,2023,36(11):13.[doi:10.3969/j.issn.1006-1959.2023.05.003]
[9]邓裕山,沈国双.AP1基因家族与恶性肿瘤的关系研究[J].医学信息,2022,35(06):56.[doi:10.3969/j.issn.1006-1959.2022.06.014]
DENG Yu-shan,SHEN Guo-shuang.Study on the Relationship Between AP1 Gene Family and Malignant Tumors[J].Medical Information,2022,35(11):56.[doi:10.3969/j.issn.1006-1959.2022.06.014]